Second Cohort Joins Safety Study to Gather Data for FDA
Decentralized Clinical Trial Allows for Consumer Participation During COVID (DENVER, Colo.) — April 15, 2021 — Validcare announced today the addition of a second cohort …
Clinical Study Reports Preliminary Results of Liver Safety
Investigators report to FDA no evidence of liver toxicity in the 839 adults consuming oral CBD (DENVER, Colo.) — March 23, 2021 — After seven …
Validcare Joins Council for Responsible Nutrition to Help Support and Advance Scientific Research
Supplement companies gain access to decentralized clinical research platform (DENVER, Colo.) — March 16, 2021 — ValidCare, a leading provider of digital decentralized patient-centric clinical …
IRB Approved Observational Safety Study Is Now Underway
Validcare Study Platform is Capturing Real World Evidence on Effects of CBD (DENVER, Colo.) — September 2, 2020 — Validcare announced today that enrollment has …
Leading Brands Collaborate to Sponsor Observational Research Aimed at Answering FDA’s Safety Concerns
Validcare to capture Real World Evidence on CBD product composition, effects and liver function (DENVER, Colo.) — June 9, 2020 — ValidCare announced today that Boulder …
Wall St. Journal: Cloudy Regulation Slows CBD Seep into Food and Drinks
Startups see an opening as big brands ease up on their cannabidiol research by Annie Gasparro, Jan. 9 2020 Big food-and-drink companies are slowing work on …
Watch What You Say! Making Product Claims Can Put Your Business at Risk
Patrick McCarthy, CEO at Validcare Leads Panel on How Supplement Brands Can More Safely Make Product Claims and Meet Regulatory Requirements
